Employers Limit Expansion of GLP-1 Obesity Drug Coverage

A survey reveals that employers are not significantly expanding coverage for GLP-1 obesity drugs, with many finding alternative ways to manage costs.

8 Jul, 13:19 — 8 Jul, 13:19

Post Share

Sources

Showing 1 of 1 sources

cnbcMostly Factual56d ago

Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.

Read full article →

Employers Limit Expansion of GLP-1 Obesity Drug Coverage

Sources

Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Related Stories

US Considers Targeted Chip Tariffs Amid Trade Discussions With Mexico

OPEC+ Expected to Maintain Current Oil Production Quotas

New York City Public Schools Ban Artificial Intelligence for Students Through Eighth Grade

Uber and Wayve Launch Driverless Robotaxi Service in London